Post Profile






How to Protect a Drug Patent? Sell it to a Native American Tribe

Under a novel deal, Allergan will pay the Saint Regis Mohawk tribe $13.75 million. In exchange, the tribe will claim sovereign immunity as grounds to dismiss a patent challenge.
read more

share

Related Posts


Allergan to buy liver drug maker Tobira in deal potentially valued at $1.7B

Business & Finance : USAToday: Money

Pharmaceutical manufacturer Allergan plc said Tuesday it has agreed to buy liver disease drug developer Tobira Therapeutics in a deal valued at up to about $1.7 billion.  Allergan, headquartered in Dublin, Ireland, will pay $28.    ...

Allergan, Argentum settle patent dispute over eye drug Restasis

Health : Reuters: Health

(Reuters) - U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, Restasis.

Sovereign Immunity Excuses University of Florida from IPR Challenge

Industries / Law : Patent Law Blog (Patently-O)

by Dennis Crouch As public universities continue to obtain more patents, issues of sovereign immunity continue to arise. In a recent decision, the Patent Trial and Appeal Board (PTAB) dismissed a trio of inter partes review proceedi...

Allergan: Creating Sovereign Immunity with Tribal Pass-Through

Industries / Law : Patent Law Blog (Patently-O)

by Dennis Crouch It appears that Allergan’s attorneys have been working overtime.  In a bold move, Allergan has transferred title to all of its Restasis patents to the Saint Regis Mohawk Tribe.  I don’t know if I’m laughing or cryin...

Allergan pays Mohawk Tribe to protect patents from challenges

Health : Reuters: Health

(Reuters) - Allergan Plc will transfer to the Saint Regis Mohawk Tribe rights to its blockbuster Restasis dry-eye treatment, the drugmaker said on Friday, in an unusual deal to protect it from patent challenges.

Comments


Copyright © 2016 Regator, LLC